XML 46 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2

SEGMENT AND GEOGRAPHIC INFORMATION (Tables)

9 Months Ended

Sep. 30, 2022

Segment Reporting [Abstract]

Schedule of Net Sales and Profit by Segments

Net sales and profit by each reportable segment for the three and nine months ended September 30, 2022 and 2021 are as follows:

			Three Months Ended September 30,												Nine Months Ended September 30,
Dollars in thousands			2022						2021						2022						2021
Segment Net Sales
Codman Specialty Surgical			$	249,796					$	256,497					$	754,967					$	754,575
Tissue Technologies			135,395						130,364						404,677						382,349
Total revenues			$	385,191					$	386,861					$	1,159,644					$	1,136,924
Segment Profit
Codman Specialty Surgical			$	105,717					$	110,686					$	308,073					$	331,460
Tissue Technologies			59,754						57,730						175,273						172,154
Segment profit			165,471						168,416						483,346						503,614
Amortization			(3,141)						(4,113)						(10,339)						(12,838)
Corporate and other			(97,281)						(107,864)						(301,927)						(351,769)
Operating income			$	65,049					$	56,439					$	171,080					$	139,007

Total revenue by major geographic area consisted of the following:

			Three Months Ended September 30,												Nine Months Ended September 30,
Dollars in thousands			2022						2021						2022						2021
United States			$	282,016					$	275,775					$	832,714					$	801,754
Europe			38,301						46,458						128,907						140,714
Asia Pacific			42,774						45,015						133,856						136,616
Rest of World			22,100						19,613						64,167						57,840
Total Revenues			$	385,191					$	386,861					$	1,159,644					$	1,136,924

Schedule of Geographic Revenue by Area

Net sales and profit by each reportable segment for the three and nine months ended September 30, 2022 and 2021 are as follows:

			Three Months Ended September 30,												Nine Months Ended September 30,
Dollars in thousands			2022						2021						2022						2021
Segment Net Sales
Codman Specialty Surgical			$	249,796					$	256,497					$	754,967					$	754,575
Tissue Technologies			135,395						130,364						404,677						382,349
Total revenues			$	385,191					$	386,861					$	1,159,644					$	1,136,924
Segment Profit
Codman Specialty Surgical			$	105,717					$	110,686					$	308,073					$	331,460
Tissue Technologies			59,754						57,730						175,273						172,154
Segment profit			165,471						168,416						483,346						503,614
Amortization			(3,141)						(4,113)						(10,339)						(12,838)
Corporate and other			(97,281)						(107,864)						(301,927)						(351,769)
Operating income			$	65,049					$	56,439					$	171,080					$	139,007

Total revenue by major geographic area consisted of the following:

			Three Months Ended September 30,												Nine Months Ended September 30,
Dollars in thousands			2022						2021						2022						2021
United States			$	282,016					$	275,775					$	832,714					$	801,754
Europe			38,301						46,458						128,907						140,714
Asia Pacific			42,774						45,015						133,856						136,616
Rest of World			22,100						19,613						64,167						57,840
Total Revenues			$	385,191					$	386,861					$	1,159,644					$	1,136,924

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration